The AP2A2 Knockout Jurkat Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the Jurkat human T-lymphocyte line, designed to disrupt the AP2A2 gene. This heterogeneous population offers a loss-of-function model for investigating AP2A2-dependent mechanisms without clonal isolation, enabling studies of endocytic processes in a biologically variable context relevant to T-cell biology.
Jurkat cells originate from an acute T-cell leukemia patient and serve as a well-established model for T-cell receptor (TCR) signaling, apoptosis, and immunological research. Their robust growth and ease of manipulation make them an ideal host for examining clathrin-mediated endocytosis and receptor trafficking in a T-lymphocyte background, where membrane dynamics are tightly linked to immune function.
AP2A2 encodes the ??-adaptin subunit of the adaptor protein complex 2 (AP-2), which is essential for clathrin-mediated endocytosis. The AP-2 complex is regulated by AAK1 kinase, PIP2, and ARF6 GTPase, and it selects cargo including transferrin receptor (TfR), LDL receptor (LDLR), and EGFR. AP2A2 interacts with AP2 subunits (AP2B1, AP2M1, AP2S1), DAB2, LDLRAP1, Epsin, and HIP1R to facilitate vesicle formation. CRISPR/Cas9-mediated disruption of AP2A2 impairs internalization of these receptors, leading to altered downstream signaling, such as Notch pathway regulation, and endosomal trafficking marked by Rab5.
In Jurkat T cells, AP2A2 knockout provides a unique platform to dissect the role of endocytosis in TCR signaling, cytokine receptor turnover, and the recycling of immune regulatory molecules. As a leukemic cell line, it also permits exploration of how endocytic defects contribute to cancer cell proliferation and survival. Moreover, the model is valuable for studying the molecular basis of neurodevelopmental disorders and hypercholesterolemia, where AP2A2 dysfunction has been implicated, albeit in a T-cell context that allows for high-throughput functional assays.
Researchers can employ AP2A2 Knockout Jurkat Polyclonal Cells in transferrin uptake assays, immunofluorescence for clathrin and AP-2, flow cytometry to quantify surface levels of TfR and EGFR, and co-immunoprecipitation to probe AP-2 complex interactions. Further applications include live-cell imaging of endocytosis, RNA-seq-based transcriptome profiling, and drug targeting studies focused on endocytic pathways in T-cell leukemia. For detailed protocols and support, contact Ascent Research.
